Replies to post #126808 on Avid Bioservices Inc (CDMO)

[investingdog]

<<you don't understand this..subset/final results...>>


This may be, show me where in the report they say 16.5 months was for a subset. Here is that quote again:


"To date, 27 patients (68%) have had documented disease progression and 23 patients (58%) have died. Five patients (13%) are still on active treatment. The median progression-free survival was 7.9 months (95% CI, 6.0-11.1) (Fig. 1), indicating a statistically significant improvement over the historical control (evidenced by the lower boundary of the confidence interval above the historical median progression-free survival mark of 4.5 months). Median overall survival was 16.5 months (95% CI, 13.6-31.2) (Fig. 1)."